US OptionsDetailed Quotes
ALNY250117C240000
- 3.70
- -2.30-38.33%
15min DelayClose Jan 10 16:00 ET
3.70High3.57Low
3.57Open6.00Pre Close41 Volume544 Open Interest240.00Strike Price15.15KTurnover52.32%IV2.40%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry3.70Extrinsic Value100Contract SizeAmericanOptions Type0.4677Delta0.0247Gamma42.88Leverage Ratio-0.5609Theta0.0176Rho20.05Eff Leverage0.1221Vega
Alnylam Pharmaceuticals Stock Discussion
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet